Unknown

Dataset Information

0

Increased hexosamine biosynthetic pathway flux alters cell-cell adhesion in INS-1E cells and murine islets.


ABSTRACT:

Purpose

In type 2 Diabetes, β-cell failure is caused by loss of cell mass, mostly by apoptosis, but also by simple dysfunction (dedifferentiation, decline of glucose-stimulated insulin secretion). Apoptosis and dysfunction are caused, at least in part, by glucotoxicity, in which increased flux of glucose in the hexosamine biosynthetic pathway plays a role. In this study, we sought to clarify whether increased hexosamine biosynthetic pathway flux affects another important aspect of β-cell physiology, that is β-cell-β-cell homotypic interactions.

Methods

We used INS-1E cells and murine islets. The expression and cellular distribution of E-cadherin and β-catenin was evaluated by immunofluorescence, immunohistochemistry and western blot. Cell-cell adhesion was examined by the hanging-drop aggregation assay, islet architecture by isolation and microscopic observation.

Results

E-cadherin expression was not changed by increased hexosamine biosynthetic pathway flux, however, there was a decrease of cell surface, and an increase in intracellular E-cadherin. Moreover, intracellular E-cadherin delocalized, at least in part, from the Golgi complex to the endoplasmic reticulum. Beta-catenin was found to parallel the E-cadherin redistribution, showing a dislocation from the plasmamembrane to the cytosol. These changes had as a phenotypic consequence a decreased ability of INS-1E to aggregate. Finally, in ex vivo experiments, glucosamine was able to alter islet structure and to decrease surface abundandance of E-cadherin and β-catenin.

Conclusion

Increased hexosamine biosynthetic pathway flux alters E-cadherin cellular localization both in INS-1E cells and murine islets and affects cell-cell adhesion and islet morphology. These changes are likely caused by alterations of E-cadherin function, highlighting a new potential target to counteract the consequences of glucotoxicity on β-cells.

SUBMITTER: Lofrumento DD 

PROVIDER: S-EPMC10403402 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>In type 2 Diabetes, β-cell failure is caused by loss of cell mass, mostly by apoptosis, but also by simple dysfunction (dedifferentiation, decline of glucose-stimulated insulin secretion). Apoptosis and dysfunction are caused, at least in part, by glucotoxicity, in which increased flux of glucose in the hexosamine biosynthetic pathway plays a role. In this study, we sought to clarify whether increased hexosamine biosynthetic pathway flux affects another important aspect of β-cell  ...[more]

Similar Datasets

| S-EPMC11507681 | biostudies-literature
| S-EPMC3919173 | biostudies-literature
| S-EPMC3057791 | biostudies-literature
| S-EPMC7536384 | biostudies-literature
| S-EPMC6168390 | biostudies-literature
| S-EPMC6411693 | biostudies-literature
2012-12-14 | GSE42897 | GEO
| S-EPMC4080978 | biostudies-literature
| S-EPMC6438539 | biostudies-literature
| S-EPMC3035713 | biostudies-literature